HABEEB ARAR: Open Payments
NPI 1881857043 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 42 payments from 10 companies in 2025. Trend: 2023 $823 · 2024 $339 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $177 |
| ABBVIE INC. | 7 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $131 |
| Neurocrine BioSciences, Inc. | 5 | $101 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
| Alkermes, Inc. | 4 | $83 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| Lundbeck LLC | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
Products named: COBENFY, VRAYLAR, CAPLYTA, INGREZZA, FANAPT, ARISTADA, SPRAVATO, REXULTI.
Industry payments across OH — which companies pay providers there.
